Jonah Comstock

Forty-one percent of consumers have never heard of telemedicine, according to a new survey of 1,200 consumers conducted by Survey Sampling International on behalf of HealthMine.

Palo Alto-based novel blood test company Theranos was granted a waiver from the FDA allowing the company to offer its first FDA-cleared blood test, its herpes simplex 1 virus IgG (HSV IgG) test, outside of a lab setting.

New York City-based Blueprint Health has announced its eighth class of startups.

MedWatcher, a tool for adverse event reporting, that the FDA worked on with Epidemico.

Utah health system Intermountain Healthcare -- and other, as yet unknown providers -- appear to be investigating AliveCor's smartphone ECG device in a clinical context, to determine whether the iPhone version of the device is comparable with traditional 12-lead ECGs.

Ancestry.

It's been clear for a while that Google sees the future of the Glass program in the enterprise, rather than through the Explorer program or directly to consumers.

NovioSense's glucose sensor.

Philadelphia-based digital health accelerator DreamIt Health has announced its third class.

Fitbit CEO James Park Forget everything you thought you knew about Fitbit.